002462 Cachet Pharmaceutical
WatchlistCachet Pharmaceutical News
Jiashitang: Financial Report for the Half Year 2023
Jiashitang: Half-year summary table of non-operating capital usage and other related capital transactions
Jiashitang: Announcement on the Appointment of the Company\'s Board Secretary
Gashitang: An Law Firm\'s Legal Opinion on the 2022 Annual General Meeting of Shareholders of Gashitang Pharmaceutical Co., Ltd.
Jiashitang: Announcement of Resolutions of the 2022 Annual General Meeting of Shareholders
Jiashitang: 2022 Announcement on Preparation for Calculating Goodwill Impairment
Gashido: Notice of Annual General Meeting of Shareholders
Gashitang: 2023 Risk Preference Statement
Jiashitang: Announcement of Resolutions of the 2022 Second Extraordinary General Meeting of Shareholders
Jiashitang: Legal opinion of Ann Law Firm on the 2022 Second Extraordinary General Meeting of Shareholders of Gashitang Pharmaceutical Co., Ltd.
Jiashitang: Announcement on the Board of Directors and Supervisory Board's Announcement on the Completion of General Elections and Appointment of Senior Managers
Jiashitang: Announcement of Resolutions of the 2022 First Extraordinary General Meeting of Shareholders
Jiashitang: Legal opinion of Ann Law Firm on the 2022 First Extraordinary General Meeting of Shareholders of Gashitang Pharmaceutical Co., Ltd.
Jiashido: Announcement on the change of independent directors
Kashido: Announcement on the results of the election of employee representatives and supervisors
Jiashido: Announcement on the election of the Supervisory Board for a new term
Jiashitang: Announcement on the election of a new board of directors
Jiashitang: Notice on holding the second Extraordinary General Meeting of Shareholders in 2022
Jiashitang: Announcement on the Appointment of the Company's Vice President
Jiashitang: Announcement on the departure of the company's director, vice president, and secretary of the board of directors